相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
Devarajan Nalini et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer
Xiaoliang Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
Chao-Yue Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin
Caijun Dong et al.
ONCOTARGETS AND THERAPY (2019)
Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers
Marijke I. Zonneveld et al.
CANCERS (2019)
HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
Basmina Parmakhtiar et al.
MOLECULAR CANCER RESEARCH (2019)
Circulating MicroRNAs in Cancer: Potential and Challenge
Mengying Cui et al.
FRONTIERS IN GENETICS (2019)
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
Youngjin Han et al.
ONCOGENE (2019)
Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
Ajimu Keremu et al.
BIOSCIENCE REPORTS (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance
Yinjie Su et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Enhancement of cisplatin efficacy by lipid-CaO2 nanocarrier-mediated comprehensive modulation of the tumor microenvironment
Chuanchuan He et al.
BIOMATERIALS SCIENCE (2019)
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
Elisabetta Gabano et al.
DALTON TRANSACTIONS (2018)
Scutellaria baicalensis targets the hypoxia-inducible factor-1 and enhances cisplatin efficacy in ovarian cancer
Imran Hussain et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins
Kalpana Deepa Priya Dorayappan et al.
ONCOGENE (2018)
The role of HIF-1α in chemo-/radioresistant tumors
Yu Xia et al.
ONCOTARGETS AND THERAPY (2018)
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
Eroje M. Ahmed et al.
CELLULAR ONCOLOGY (2018)
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1 alpha and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
Christophe Deben et al.
CANCERS (2018)
Role of HIF-1 in Cancer Progression: Novel Insights. A Review
Aldo Pezzuto et al.
CURRENT MOLECULAR MEDICINE (2018)
Hypoxia-activated prodrugs and redox-responsive nanocarriers
Yun Zeng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo
Yan Huang et al.
CANCER COMMUNICATIONS (2018)
Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK-HIF-1α
Yue Pan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer
Chang-Sheng Lin et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance
Yi Xuan et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia
Flourina Kumar Thakor et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
Xue Feng et al.
ONCOTARGETS AND THERAPY (2017)
A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma
Xiang Qi et al.
ONCOTARGET (2017)
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
Giuseppina Roscigno et al.
ONCOTARGET (2017)
Cancer Cell Membrane-Biomimetic Oxygen Nanocarrier for Breaking Hypoxia-Induced Chemoresistance
Hao Tian et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway
Qiang Fu et al.
CANCER CELL INTERNATIONAL (2017)
Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline-A study using zebrafish model
Jhansi Rani Nathan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer
Fuquan Zhang et al.
CANCER SCIENCE (2016)
Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
Shreesh Ojha et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells
Shrikant Pradhan et al.
ONCOTARGET (2016)
MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer
Xiaoxiao Ge et al.
ONCOTARGET (2016)
Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
Jhih-Pu Syu et al.
ONCOTARGET (2016)
Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
Guifang Yu et al.
CANCER CELL INTERNATIONAL (2015)
Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells
Leli Zeng et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
Akshada Sawant et al.
DNA REPAIR (2015)
Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy
Michal Pastorek et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
Carina Fischer et al.
MOLECULAR CANCER (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
Jin Gu Lee et al.
RESPIRATORY RESEARCH (2015)
Imaging Tumor Hypoxia to Advance Radiation Oncology
Chen-Ting Lee et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Targeting mitochondria by α-tocopheryl succinate overcomes hypoxia-mediated tumor cell resistance to treatment
Andrey V. Kulikov et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
HIF-1 Signaling in Drug Resistance to Chemotherapy
N. A. Warfel et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer
Xue-Pu Sun et al.
FEBS JOURNAL (2014)
Survivin as a Preferential Target for Cancer Therapy
Mahsa Mobahat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study
Paul A. DiSilvestro et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Multiple functions of hypoxia-regulated miR-210 in cancer
Qin Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells
Hai-Shan Peng et al.
PLOS ONE (2014)
Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
Oscar Arrieta et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo
Sutapa Sinha et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax
Chae Won Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia
Makoto Shimanishi et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2013)
Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells
Li Jiang et al.
MOLECULAR MEDICINE REPORTS (2013)
Hypoxia-Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
Jennifer Adamski et al.
PLOS ONE (2013)
Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer
Hak-Su Kim et al.
APOPTOSIS (2012)
Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
Prabodh K. Kandala et al.
BMC MEDICINE (2012)
Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4
Yu-Chih Wu et al.
CANCER RESEARCH (2012)
Hypoxia-Inducible Factor-1α and Excision Repair Cross-Complementing 1 in Patients with Small Cell Lung Cancer Who Received Front-Line Platinum-Based Chemotherapy A Retrospective Study
Gyeong-Won Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
Saskia E. Rademakers et al.
BMC CANCER (2011)
Role of Cyclophilin B in Tumorigenesis and Cisplatin Resistance in Hepatocellular Carcinoma in Humans
Yeonghwan Kim et al.
HEPATOLOGY (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Novel Combinational Treatment of Cisplatin with Cyclophilin A Inhibitors in Human Heptocellular Carcinomas
Jinhwa Lee
ARCHIVES OF PHARMACAL RESEARCH (2010)
An Overview of Cyclophilins in Human Cancers
J. Lee et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Cellular Responses to Cisplatin-Induced DNA Damage
Alakananda Basu et al.
JOURNAL OF NUCLEIC ACIDS (2010)
An Akt/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
Chi Keung Lau et al.
CLINICAL CANCER RESEARCH (2009)
Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
Samantha Lin Chiou Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells
Xin-zhi Huang et al.
CANCER BIOLOGY & THERAPY (2008)
Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells
J. Hao et al.
CANCER GENE THERAPY (2008)
Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death
Kyu Jin Choi et al.
CANCER RESEARCH (2007)
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Xianrang Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo
K Yao et al.
BRITISH JOURNAL OF CANCER (2005)
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
RD Guzy et al.
CELL METABOLISM (2005)
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
S Koch et al.
BRITISH JOURNAL OF CANCER (2003)
分享论文
